Summary
Johnson & Johnson (JNJ) filed an 8-K report on April 19, 2005, to announce its financial results for the first quarter ended April 3, 2005. The filing primarily references an attached press release and supplementary financial data, providing investors with key sales and earnings figures for the period. This report serves as the official disclosure mechanism for J&J's Q1 2005 performance, allowing stakeholders to assess the company's operational and financial health.
Key Highlights
- 1JNJ reported its first quarter 2005 sales and earnings on April 19, 2005.
- 2The filing includes a press release detailing the Q1 2005 financial results.
- 3Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the first quarter are provided as exhibits.
- 4The report confirms J&J's adherence to reporting obligations under the Securities Exchange Act of 1934.
- 5Stephen J. Cosgrove, Chief Accounting Officer, signed the report, indicating official company authorization.
- 6The event date for the earliest reported event is April 19, 2005, aligning with the press release issuance.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide investors with Johnson & Johnson's sales and earnings results for the first quarter ended April 3, 2005. It serves as a formal disclosure of the company's financial performance for that period.
This report includes a press release (Exhibit 99.15) that announces the first quarter sales and earnings. It also contains unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the first quarter (Exhibit 99.20).
Johnson & Johnson announced its sales and earnings for the first quarter ended April 3, 2005, on April 19, 2005.
The filing was signed on behalf of Johnson & Johnson by Stephen J. Cosgrove, Chief Accounting Officer, indicating official authorization of the disclosed financial information.